InspireMD, Inc. Series B Warrants
NSPRZ
NSPRZ was delisted on the 14th of March, 2022.
3 hedge funds and large institutions have $162K invested in InspireMD, Inc. Series B Warrants in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$262K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$12.2K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$7.02K |
Top Sellers
NSPRZ Hedge Fund Activity: Q2 2017 in Review
3 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q2 2017, worth a combined $162K.
Buyers outnumbered sellers: 3 funds opened new NSPRZ positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $262K.
- 3 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q2 2017, up from 0 in Q1 2017.
- Funds reported $162K of InspireMD, Inc. Series B Warrants stock for Q2 2017.
- 3 funds opened new InspireMD, Inc. Series B Warrants positions in Q2 2017 and 0 closed out, a net change of +3 holders.
- The largest InspireMD, Inc. Series B Warrants buyer in Q2 2017 was Sabby Management, an estimated $262K added.
Based on aggregated 13F filings for Q2 2017.